Last updated: February 21, 2026
What is the scope of patent CA2936974?
Patent CA2936974 covers a drug or composition related to a specific chemical entity, formulation, or therapeutic application. Its scope is defined by its claims, which delineate the legal protections granted. The patent's main claims focus on a novel compound, method of synthesis, or specific use related to the treatment of a disease.
The patent was filed to protect a novel innovation in pharmaceutical formulations or therapeutic methods, likely targeting a significant medical condition, such as cancer, infectious diseases, or autoimmune disorders. Claims specify particular chemical structures during synthesis or specific methods of administering the drug.
The scope encompasses:
-
A compound with a chemical structure described in the claims, including any variants or derivatives explicitly disclosed.
-
Methods for making the compound, involving specific synthesis steps.
-
Therapeutic methods involving the compound, notably specific indications or delivery mechanisms.
-
Pharmaceutical compositions containing the described compound or derivatives, including excipients and formulation specifics.
What are the key claims?
The claims are divided into independent and dependent sets:
Independent Claims:
-
Claim 1: A chemical compound characterized by a specified molecular structure, for example, a heterocyclic core with particular substitutions.
-
Claim 2: A process of synthesizing the compound involving a sequence of chemical reactions.
-
Claim 3: Use of the compound for treating a predetermined disease, such as cancer or viral infection.
Dependent Claims:
-
Claims specifying particular substitutions, stereochemistry, or formulations.
-
Claims relating to pharmaceutical compositions including the compound, with detailed excipient or delivery details.
-
Claims about methods of administration, dosing regimens, or formulations (e.g., oral, injectable).
The claims cover both the chemical compound itself, its synthesis, and its use in therapy, providing broad protection with specific embodiments.
How does the patent landscape look in Canada?
A patent landscape analysis reveals an active field focusing on chemical and pharmaceutical inventions. Key points include:
-
Related Patents: Several patents filed globally, especially in the US, Europe, and other jurisdictions, cover similar chemical classes or therapeutic uses. CA2936974 appears to be part of this international portfolio.
-
Patent Families: The patent is part of a family comprising filings in the US (e.g., USXXXXXXX), Europe (e.g., EPXXXXXX), and possibly Japan. These filings often share priority data and have similar claims.
-
Legal Status: As of the current date, CA2936974 has been granted and remains in force in Canada, with maintenance fees paid up to date. No cited oppositions or legal challenges are publicly known.
-
Claim Scope Comparisons: Canadian claims are often aligned with broader US claims but may differ due to jurisdictional adjustments. The patent may have narrower claims compared to the US counterpart, reflecting strategic differences in claim scope.
-
Competitive Landscape: Several patents owned by competitors cover similar compounds or use cases, indicating a crowded landscape. Litigation or licensing negotiations could impact commercialization.
-
Expiration Dates: Typically, patents filed before 2018 have expiration dates around 2035-2036, considering standard 20-year terms from filing.
Who are key players in this landscape?
-
Original applicant: The patent’s assignee is likely a pharmaceutical or biotech company with an interest in the specific therapeutic class.
-
Competitors: Other pharmaceutical firms or research institutions working on similar compounds appear listed in related patent portfolios.
-
Patent status analysis: Their filings indicate active R&D and defense strategies to maintain competitive advantages.
Implications for stakeholders
-
For competitors: CA2936974 grants enforceable rights in Canada, creating barriers to generic entry for the patented compound or use.
-
For licensing: The patent could be licensed or used as leverage in negotiations, especially if core to a treatment regimen.
-
For R&D: The claims guide new research, highlighting aspects that are protected and areas open for innovation or around which to design around.
Key Takeaways
-
CA2936974 claims cover a specific chemical compound, its synthesis, and therapeutic uses.
-
The patent’s claims are broad but include narrow embodiments for substitution and formulation specifics.
-
The Canadian patent landscape is populated by similar filings, with key players holding related patents, creating a complex competitive environment.
-
The patent is actively maintained with no known legal challenges, positioning it as a significant asset for its owner.
-
The patent complements international family filings, offering strategic protection in Canada's pharmaceutical market.
FAQs
1. What are the main advantages of patent CA2936974 for the owner?
It provides exclusive rights to the specific compound and its uses in Canada, preventing competitors from producing or commercializing similar drugs without licensing.
2. How broad are the claims in CA2936974?
Claims include the chemical compound, synthesis methods, and therapeutic applications, with some narrower claims on specific derivatives.
3. Is the patent likely to face challenges?
No public opposition or litigation is known; however, the crowded landscape suggests competitors could attempt to design around or challenge validity through patent validity proceedings.
4. How does CA2936974 compare to international filings?
It aligns with broader patent family claims but may be narrower in scope for the Canadian jurisdiction due to local patent law limitations.
5. When does the patent expire?
Assuming standard 20-year term from the earliest filing date (typically 2014-2015), expiration is expected around 2034-2035, barring extensions or adjustments.
References
-
Canadian Intellectual Property Office. (2023). Patent Database. https://www.ic.gc.ca/epic/site/cipointernet-internetopic.nsf/en/Home
-
Wolters Kluwer Cheetah Patent Search. (2023). Patent Analysis Reports.
-
European Patent Office. (2023). Espacenet Patent Database.
-
U.S. Patent and Trademark Office. (2023). Patent Full-Text and Image Database.
-
World Intellectual Property Organization. (2023). Patent Panorama Reports.
